HCPCS Level IIdrugActive
J1305
Inj, evinacumab-dgnb, 5mg
BETOS: O1E
Effective: 2021-10-01
Description
Injection, evinacumab-dgnb, 5mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Evkeeza
Manufacturer
Regeneron Pharmaceuticals, Inc.
HCPCS Dosage
5 MG
Billing Units
240.0000
2
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.